Literature DB >> 8172068

Heart rate variability: a measure of cardiac autonomic tone.

P K Stein1, M S Bosner, R E Kleiger, B M Conger.   

Abstract

Analysis of HRV based on routine 24-hour Holter recordings provides a sensitive, noninvasive measurement of autonomic input to the heart. HRV can be measured in the time or frequency domain. Each frequency domain variable correlates at least r = 0.85 with a time domain variable. Thus time domain measures can be used as surrogates for frequency domain measures which may simplify future studies. Abnormalities of autonomic input to the heart, which are indicated by decreased indices of HRV, are associated with increased susceptibility to ventricular arrhythmias. Decreased indices of HRV are also associated with CHF, diabetes, and alcoholic cardiomyopathy. Decreased indices of HRV are an independent risk factor for mortality post MI and in patients with advanced CHF. Medications can also affect HRV, and that effect may become an important clinical consideration, especially in high-risk patients.

Entities:  

Mesh:

Year:  1994        PMID: 8172068     DOI: 10.1016/0002-8703(94)90059-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  128 in total

1.  The relationship between heart rate recovery and heart rate variability in coronary artery disease.

Authors:  Harun Evrengul; Halil Tanriverdi; Sedat Kose; Basri Amasyali; Ayhan Kilic; Turgay Celik; Hasan Turhan
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

2.  Exacerbation of myocardial dysfunction and autonomic imbalance contributes to the estrogen-dependent chronic hypotensive effect of ethanol in female rats.

Authors:  Mahmoud M el-Mas; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2012-01-24       Impact factor: 4.432

3.  Central GABAA receptors are involved in inflammatory and cardiovascular consequences of endotoxemia in conscious rats.

Authors:  Marwa Y Sallam; Sahar M El-Gowilly; Abdel-Galil A Abdel-Galil; Mahmoud M El-Mas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-21       Impact factor: 3.000

4.  Autonomic nervous system reactivity to positive and negative mood induction: the role of acute psychological responses and frontal electrocortical activity.

Authors:  Willem J Kop; Stephen J Synowski; Miranda E Newell; Louis A Schmidt; Shari R Waldstein; Nathan A Fox
Journal:  Biol Psychol       Date:  2010-12-21       Impact factor: 3.251

5.  Cardiac vagal outflow after aerobic training by analysis of high-frequency oscillation of the R-R interval.

Authors:  Antti M Kiviniemi; Arto J Hautala; Timo H Mäkikallio; Tapio Seppänen; Heikki V Huikuri; Mikko P Tulppo
Journal:  Eur J Appl Physiol       Date:  2006-01-17       Impact factor: 3.078

6.  Is heart rate variability a valid parameter to predict sudden death in patients with Becker's muscular dystrophy?

Authors:  E Ammendola; V Russo; L Politano; L Santangelo; R Calabrò
Journal:  Heart       Date:  2006-11       Impact factor: 5.994

7.  Upregulation of cardiac NOS due to endotoxemia and vagal overactivity contributes to the hypotensive effect of chronic ethanol in female rats.

Authors:  Mahmoud M El-Mas; Ming Fan; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2010-10-21       Impact factor: 4.432

8.  The influence of trait and state rumination on cardiovascular recovery from a negative emotional stressor.

Authors:  Brenda L Key; Tavis S Campbell; Simon L Bacon; William Gerin
Journal:  J Behav Med       Date:  2008-03-19

9.  On the importance of inhibition: central and peripheral manifestations of nonlinear inhibitory processes in neural systems.

Authors:  Julian F Thayer
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

10.  TRPA1 mediates the cardiac effects of acrolein through parasympathetic dominance but also sympathetic modulation in mice.

Authors:  Nicole Kurhanewicz; Allen Ledbetter; Aimen Farraj; Mehdi Hazari
Journal:  Toxicol Appl Pharmacol       Date:  2018-04-05       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.